B. Magenheimer

发表

MAP/ERK Kinase Kinase 1 (MEKK1) Mediates Transcriptional Repression by Interacting with Polycystic Kidney Disease-1 (PKD1) Promoter-bound p53 Tumor Suppressor Protein*

S. Puri, C. Widmann, M. R. Islam, 2010, The Journal of Biological Chemistry.

Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.

B. Magenheimer, R. Maser, J. Calvet, 2006, Journal of the American Society of Nephrology : JASN.

Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation.

B. Magenheimer, J. Calvet, Xiaogang Li, 2012, Kidney international.

Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype*

James P Calvet, B. Magenheimer, J. Calvet, 2004, Journal of Biological Chemistry.

Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.

B. Magenheimer, J. Calvet, D. Wallace, 2016, Journal of the American Society of Nephrology : JASN.

Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease

B. Magenheimer, R. Maser, J. Calvet, 2018, Scientific Reports.

Polycystin-1 Regulates Skeletogenesis through Stimulation of the Osteoblast-specific Transcription Factor RUNX2-II*

B. Magenheimer, Zhousheng Xiao, L. Quarles, 2008, Journal of Biological Chemistry.

Transient transfection assays for analysis of signal transduction in renal cells.

B. Magenheimer, R. Maser, J. Calvet, 2003, Methods in molecular medicine.

Identification of the major site of in vitro PKA phosphorylation in the polycystin-1 C-terminal cytosolic domain.

B. Magenheimer, R. Maser, J. Calvet, 1999, Biochemical and biophysical research communications.

Quinomycin A reduces cyst progression in polycystic kidney disease

W. Wang, B. Magenheimer, J. Calvet, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Quinomycin A reduces cyst progression in polycystic kidney disease

B. Magenheimer, J. Calvet, D. Wallace, 2020, bioRxiv.

Constitutive signaling by the C-terminal fragment of polycystin-1 is mediated by a tethered peptide agonist

B. Magenheimer, R. Maser, Ericka Nevarez Munoz, 2021, bioRxiv.

pathwaysmodels via cAMP and EGFR-Src-MEK stimulate fluid secretion and cyst growth of in vitro Endogenous concentrations of ouabain act as a cofactor to

B. Magenheimer, J. Calvet, D. Wallace, 2016 .

Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells

B. Magenheimer, J. Calvet, D. Wallace, 2015, The Journal of Membrane Biology.

Overexpression of the Polycystin-1 C-Tail Enhances Sensitivity of M-1 Cells to Ouabain

B. Magenheimer, R. Maser, J. Calvet, 2013, The Journal of Membrane Biology.

Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways.

B. Magenheimer, J. Calvet, D. Wallace, 2012, American journal of physiology. Renal physiology.

A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD

B. Magenheimer, R. Maser, J. Calvet, 2018, Human molecular genetics.

Sulfated glycoprotein-2 (Sgp-2) maps to mouse Chromosome 14

W. Frankel, B. Magenheimer, J. Calvet, 2004, Mammalian Genome.

Mechanism of tethered agonist-mediated signaling by polycystin-1.

B. Magenheimer, R. Maser, Y. Miao, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Overexpression of the Polycystin-1 C-Tail Enhances Sensitivity of M-1 Cells to Ouabain

B. Magenheimer, R. Maser, J. Calvet, 2013, The Journal of Membrane Biology.

Polycystin-1 Activates the Calcineurin/NFAT (Nuclear Factor of Activated T-cells) Signaling Pathway*

S. Puri, B. Magenheimer, R. Maser, 2004, Journal of Biological Chemistry.

Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease

B. Magenheimer, J. Calvet, D. Wallace, 2021, JCI insight.

Ciclopirox Olamine Induces Ferritinophagy and Ameliorates Disease Progression in Polycystic Kidney Disease

B. Magenheimer, J. Calvet, D. Wallace, 2020 .

A mouse kidney- and liver-expressed cDNA having homology with a prokaryotic parathion hydrolase (phosphotriesterase)-encoding gene: abnormal expression in injured and polycystic kidneys.

B. Magenheimer, R. Maser, J. Calvet, 1996, Gene.

Mouse plasma glutathione peroxidase. cDNA sequence analysis and renal proximal tubular expression and secretion.

B. Magenheimer, R. Maser, J. Calvet, 1994, The Journal of biological chemistry.

A tumor necrosis factor-α–mediated pathway promoting autosomal dominant polycystic kidney disease

B. Magenheimer, J. Calvet, D. Wallace, 2008, Nature Medicine.

Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease.

B. Magenheimer, R. Maser, J. Calvet, 2002, Journal of the American Society of Nephrology : JASN.

Polycystin-1 Activation of c-Jun N-terminal Kinase and AP-1 Is Mediated by Heterotrimeric G Proteins*

James P Calvet, Anna-Maria Frischauf, A. Frischauf, 2002, The Journal of Biological Chemistry.

Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells.

M. Sutters, B. Magenheimer, R. Maser, 2001, Kidney international.

The Polycystic Kidney Disease-1 Protein, Polycystin-1, Binds and Activates Heterotrimeric G-Proteinsin Vitro

T. Okamoto, B. Magenheimer, R. Maser, 1998 .

The Polycystic Kidney Disease-1 Gene Is a Target for p53-mediated Transcriptional Repression*

S. Puri, Z. Saifudeen, S. El-Dahr, 2006, Journal of Biological Chemistry.

The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease

B. Magenheimer, J. Calvet, D. Wallace, 2020, bioRxiv.

Mechanism of tethered agonist-mediated signaling by polycystin-1

B. Magenheimer, R. Maser, Y. Miao, 2021, bioRxiv.

Retinoic acid-dependent activation of the polycystic kidney disease-1 (PKD1) promoter.

S. Puri, M. R. Islam, M. Rodova, 2008, American journal of physiology. Renal physiology.

Ets factors regulate the polycystic kidney disease-1 promoter.

S. Puri, M. R. Islam, M. Rodova, 2006, Biochemical and biophysical research communications.

Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease

B. Magenheimer, R. Maser, J. Calvet, 2018, Scientific Reports.

Cilia-like Structures and Polycystin-1 in Osteoblasts/Osteocytes and Associated Abnormalities in Skeletogenesis and Runx2 Expression*

Shiqin Zhang, James P Calvet, Lynda Bonewald, 2006, Journal of Biological Chemistry.

Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells

B. Magenheimer, J. Calvet, D. Wallace, 2015, The Journal of Membrane Biology.

The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro.

T. Okamoto, B. Magenheimer, R. Maser, 1998, Biochemical and biophysical research communications.

Metanephric organ culture.

B. Magenheimer, R. Maser, J. Calvet, 2019, Methods in cell biology.

Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation.

B. Magenheimer, J. Calvet, Xiaogang Li, 2012, Kidney international.

Activation of Polycystin-1 Signaling by Binding of Stalk-derived Peptide Agonists

A. Haldane, B. Magenheimer, R. Maser, 2024, bioRxiv.